Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAMP4 Therapeutics
Biotech
Sana, CAMP4 ditch clinical-stage assets for preclinical hopefuls
Sana, CAMP4 and Crinetics have used the third quarter to refocus their pipelines on the most promising candidates.
James Waldron
Nov 7, 2025 8:13am
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am
Upstream swells IPO to $255M as it lists alongside CAMP4
Oct 11, 2024 5:18am
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
Oct 7, 2024 8:44am
BioMarin goes CAMPing, striking RNA deal with biotech
Oct 1, 2024 9:55am
Equipped with $100M in new cash, CAMP4 takes trail to the clinic
Jul 20, 2022 6:00am
